Tenders/Public Tender Announcement for Nanobody AI Model Wet Experiment Verification Service Procurement Project (ZYCGR22011901)

Open🇨🇳ChinaConsulting

Public Tender Announcement for Nanobody AI Model Wet Experiment Verification Service Procurement Project (ZYCGR22011901)

Auto-translated from Chinese

Original title: ZYCGR22011901纳米抗体AI模型湿实验验证服务采购项目公开招标公告

zycgr22011901

Published: Aug 7, 2026

Updated: Aug 7, 2026

Source: china_ccgp

About This Opportunity

This is a consulting contract in the Research sector, with a focus on Laboratories. Located in China, Asia, this opportunity is open to firms and consortiums.

Published through China CCGP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for consulting in the Research sector. Consulting assignments are typically evaluated with a strong emphasis on the technical proposal, including the methodology and qualifications of key experts. Shortlisted firms may be invited to submit financial proposals in a second stage. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Chinese

This tender, originating from China and managed by Guangdong Guoke Tendering Co., Ltd., is an open invitation for bids for a "Nanobody AI Model Wet Lab Validation Service Procurement Project" (Project Code: ZYCGR22011901). The contracting authority is identified as 'zycgr22011901'. This procurement focuses on securing specialized laboratory services essential for validating artificial intelligence (AI) models designed for nanobody research. The 'wet lab validation' aspect indicates a requirement for hands-on experimental work to test and confirm the predictions or outputs of AI algorithms related to nanobodies, which are important therapeutic proteins. Bidders are expected to provide comprehensive experimental services, potentially including the design and execution of biological assays, protein expression and purification, binding affinity measurements, and other relevant experiments. Key requirements will include demonstrating expertise in molecular biology, protein chemistry, immunology, and advanced laboratory techniques. The tender will likely specify the scope of validation, required experimental methodologies, data reporting standards, and timelines. Proven experience in supporting AI-driven drug discovery or biological research through experimental validation services is crucial for potential bidders. Adherence to laboratory safety protocols and quality management systems is mandatory.

Data provenance

This notice is sourced from China CCGP and was originally published on August 7, 2026. Last refreshed today. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About zycgr22011901

zycgr22011901 has issued 5 procurement notices on BidsFactory, including 4 currently open and 0 awarded contracts. Activity concentrates in General Supplies & Services, Research & Innovation, and Health & Medical. All notices are published for China. Notices are distributed via China CCGP. Most recent publication: August 7, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in China. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit China CCGP to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by zycgr22011901 in China. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Consulting contract in the Research & Innovation sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.